Korio is the industry’s leading compliance-centric Randomization & Trial Supply Management (RTSM) platform. Reflecting decades of hands-on experience across thousands of trial designs, Korio enables once aspirational goals around feature reusability, process repeatability, system performance, and overall system quality by embedding the latest RTSM design intelligence into our solution. Our intuitive approach to RTSM setup and management through a regulatory lens ensures audit-readiness and a predictable GxP compliant outcome on every clinical trial.
Location: United States, Pennsylvania, Doylestown
Employees: 11-50
Total raised: $6.8M
Founded date: 2021
Investors 1
Date | Name | Website |
30.10.2023 | Excelerate... | excelerate... |
Funding Rounds 1
Date | Series | Amount | Investors |
10.10.2023 | - | $6.8M | - |
Mentions in press and media 2
Date | Title | Description | Source |
16.11.2023 | Ben Franklin Healthcare Investments: $785K In Four Companies | sep.benfra... | |
10.10.2023 | Korio Secures $6.8M in Funding | Korio, a Doylestown, a PA-based technology-first Randomization & Trial Supply Management (RTSM) ... | finsmes.co... |